Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            March 26, 2019
            Published by admin on March 26, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero

            Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero Platform […]
            Do you like it?0
            Read more
            March 18, 2019
            Published by admin on March 18, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill

            Berlin (Germany) and San Diego, CA (U.S.A.), March 15, 2019 – Representatives Donald Payne, Jr. (D-NJ) and Kenny Marchant (R-TX) today introduced the ”Donald Payne Sr. […]
            Do you like it?0
            Read more
            February 18, 2019
            Published by admin on February 18, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance

            February 18, 2019, 22:00 CET – Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that […]
            Do you like it?0
            Read more
            February 4, 2019
            Published by admin on February 4, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China

            Amsterdam, the Netherlands, and Holzgerlingen, Germany, February 04, 2019, 08:00 am CET – Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of […]
            Do you like it?0
            Read more
            January 30, 2019
            Published by admin on January 30, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand

            Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 30, 2019; published at 08:00 a.m. CET — Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a […]
            Do you like it?0
            Read more
            January 8, 2019
            Published by admin on January 8, 2019
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test

            Ares Genetics to start EUR 1.3 million TRIPLE-A development project co-funded by Vienna Business Agency Initiates set-up of R&D and service laboratory in Vienna Vienna, Austria, […]
            Do you like it?0
            Read more
            December 19, 2018
            Published by admin on December 19, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

            > Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform > Collaboration leverages Ares Genetics’ antibiotic resistance database ARESdb > Short-term focus on repurposing existing […]
            Do you like it?0
            Read more
            October 12, 2018
            Published by admin on October 12, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Extends Distribution Agreement With Beijing Clear Biotech in China

            NEW YORK (GenomeWeb) – Curetis announced today that it has extended an exclusive distribution agreement with Beijing Clear Biotech (BCB), expanding it from five years to […]
            Do you like it?0
            Read more
            September 4, 2018
            Published by admin on September 4, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test

            ARESupa test aims at broad detection of microbial infections employing next-generation sequencing and artificial intelligence Curetis explores venture capital (VC) funding for Ares Genetics while assessing […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕